Navigation Links
Cynosure Reports Second Quarter 2009 Financial Results
Date:7/28/2009

WESTFORD, Mass., July 28 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced financial results for the three months ended June 30, 2009.

Second Quarter 2009 Financial Results

Revenues for the three months ended June 30, 2009 were $20.8 million, compared with $39.2 million in the same period of 2008 and $14.8 million in the first quarter of 2009. The decline from the second quarter of 2008 reflected the ongoing global economic recession and the continued restrictive credit environment in the aesthetic laser industry. The increase from the first quarter of 2009 reflected a strengthening international market coupled with a slight improvement in the North American markets. Gross margin for the second quarter of 2009 was 58.0% of total revenues, compared with 67.1% for the same period of 2008 and 60.9% in the first quarter of 2009. The decline in gross margin in the second quarter of this year compared with the second quarter of 2008 and the first quarter of 2009 reflected a higher percentage of laser revenue from international distribution, where the company's products tend to have lower sales prices.

Cynosure reported a net loss for the second quarter of 2009 of $2.3 million, or $0.18 per basic and diluted share, compared with net income of $4.7 million, or $0.36 per diluted share, in the second quarter of 2008, and a net loss of $4.0 million, or $0.32 per basic and diluted share, in the first quarter of 2009.

"An increased contribution from international markets helped to offset the continued challenges in North America in the second quarter," said Cynosure's President and Chief Executive Officer Michael Davin.
'/>"/>

SOURCE Cynosure, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Cynosure Announces Presentations at Upcoming Investor Conferences
2. Cynosure Launches New Workstation and Technology Innovations at American Academy of Dermatology Annual Meeting
3. Cynosure Introduces Affirm CO2(TM) Workstation for Advanced Ablative Therapy
4. Cynosure Announces Schedule of Upcoming Investor Conferences
5. Cynosure Appoints H. Travis Lee as Vice President of Global Marketing
6. Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth
7. Cynosure Introduces Smartlipo MPX(TM) Dual Wavelength Workstation for LaserBodySculpting(SM)
8. Cynosure Announces Upcoming Investor Presentations at Cowen and Citi Investor Conferences
9. Cynosure Reports Record Revenues and Net Income for the Fourth Quarter of 2007
10. Cynosure to Announce Fourth-Quarter and Full Year 2007 Financial Results on February 12
11. Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... 27, 2014 Reportlinker.com announces that a ... catalogue: Global Chelating Agents Market 2014-2018 ... About Chelating Agent A chelating agent is a ... metal ions, thereby forming a metal-ion complex. It ... on chemical processes, formulations, and the environment by ...
(Date:8/27/2014)... NEW YORK , Aug. 27, 2014 ... of Guggenheim Partners, today announced the hiring of veteran ... and senior equity analyst. Mr. Butler will focus on ... brings our team a wealth of experience and a ... Dante Ferrarie , Senior Managing Director and Head of ...
(Date:8/27/2014)... Aug. 27, 2014  ARCH Venture Partners, one ... in the development of seed and early-stage advanced ... fund closed with more than $400 million in ... million subscription target by more than $150 million. ... the strength and potential of our approach to ...
(Date:8/27/2014)... According to the 2013 Raw Material ... look and feel of markets for raw materials and ... will push for more branded, science-backed products.” , Natural ... market growth in the last decade as consumers increasingly ... cosmetics to fit a more ‘wellness’ lifestyle approach. ...
Breaking Biology Technology:Global Chelating Agents Market 2014-2018 2Global Chelating Agents Market 2014-2018 3Global Chelating Agents Market 2014-2018 4Guggenheim Securities Hires Analyst Charles "Tony" Butler to Expand Healthcare Coverage 2Latest ARCH Venture Partners Fund Closes Above $400 Million 2Latest ARCH Venture Partners Fund Closes Above $400 Million 3Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 2Daring to be Different Raw Materials & Ingredient Supply Shortage Fuels Vital Force™ Technology New Ingredient Enhancements 3
... of Arpida Ltd (SWX: ARPN) has approved the proposals ... A total of 73 shareholders were present at the ... represented, or 29.3% of the total,number of shares issued ... 1. Approval of the 2007 Business Report, Company ...
... NeurogesX, Inc.,(Nasdaq: NGSX ), a biopharmaceutical company ... announced it will,report results for its first quarter 2008 ... A conference call to review the results will begin ... 2008 and will be hosted by Anthony DiTonno,President and ...
... cell company,Neuralstem, Inc. (Amex: CUR ) is filing ... StemCells intentionally withheld crucial,information highly material to the patentability ... this was done with the intent to deceive,the United ... patent allowed. As,a result of these actions, Neuralstem is ...
Cached Biology Technology:Arpida Annual General Meeting of Shareholders Approves All Board Proposals 2NeurogesX to Report First Quarter 2008 Financial Results 2NeurogesX to Report First Quarter 2008 Financial Results 3Neuralstem Sues StemCells, Inc. Over New Patent 2Neuralstem Sues StemCells, Inc. Over New Patent 3
(Date:8/27/2014)... group of fish began exploring land and evolved into tetrapods ... these ancient fish used their fishy bodies and fins in ... remain scientific mysteries. , Researchers at McGill University published ... fish, called Polypterus , to help show what might ... the water. Polypterus is an African fish that ...
(Date:8/27/2014)... is easier when it is related to ability that ... learn a new melody more easily than learning how ... the Center for the Neural Basis of Cognition (CNBC)a ... Mellon Universityhave discovered a fundamental constraint in the brain ... cover story in the Aug. 28, 2014, issue of ...
(Date:8/27/2014)... LAKE CITY, Aug. 27, 2014 University of Utah ... his native Turkey, has won that nation,s highest science ... of Science. , Sekercioglu is among five researchers picked ... and Technical Research Council of Turkey. Three researchers won ... won the Special Award, which is equivalent to the ...
Breaking Biology News(10 mins):Walking fish reveal how our ancestors evolved onto land 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 2Pitt and Carnegie Mellon engineers discover why learning can be difficult 3University of Utah biologist wins Turkey's top science prize 2
... can aid forensics teams in determining if a person ... June issue of Radiology. , MDCT is comparable to ... are indicative of drowning. , "Our findings show ... reduce the need for conventional autopsy when drowning is ...
... H5N1 strain of avian influenza may hold the key to ... of researchers. In a study published today in the open ... antibodies taken from avian flu survivors in Vietnam can be ... virus in culture vitro and in mice. , The H5N1 ...
... researchers have uncovered the basis by which pregnant women ... the HIV virus works to counteract this defence. The ... in malaria-ravished regions. , Malaria is a parasitic disease ... people every year. While the disease affects mostly children, ...
Cached Biology News:'Virtual autopsy' helps identify drowning as cause of death 2Avian influenza survivors' antibodies effective at neutralising H5N1 strain 2HIV and malaria combine to adversely affect pregnant women and their infants 2
Mouse monoclonal antibody to ST8SIA2 - ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2...
Mouse monoclonal antibody raised against a partial recombinant COG2. NCBI Entrez Gene ID = COG2...
Mouse monoclonal antibody raised against a partial recombinant RAB11B. NCBI Entrez Gene ID = RAB11B...
...
Biology Products: